Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | CA9 | Q16790 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | MMP3 | P08254 | 1/20 | 0.39 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 2/20 | 0.38 |
| ▸ | RAB9A | P51151 | 2/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | PKM | P14618 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | ADORA1 | P30542 | 3/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL184515 | 0.90 | MMP2 (0.34) | NAAAALDH1A1MAPK1MMP3NPC1 | |
| Methane SCHEMBL28184594 | 0.90 | NAAA (0.40) | NAAAALDH1A1CA1CA2CA9 | |
| SCHEMBL17042226 | 0.88 | NAAA (0.39) | NAAAALDH1A1CA1CA2CA9 | |
| Biphenyl SCHEMBL2583908 | 0.87 | NAAA (0.38) | NAAAALDH1A1CA1CA2CA9 | |
| Methane SCHEMBL28013431 | 0.87 | ABL1 (0.40) | NAAAALDH1A1CYP1A2MAPK1HSD17B10 | |
| SCHEMBL3424396 | 0.87 | NCOA1 (0.39) | NAAAALDH1A1CA1CA2CA9 | |
| Biphenyl SCHEMBL28306828 | 0.86 | LTA4H (0.47) | NAAACA1CA2CA9TAAR1 | |
| SCHEMBL100094 | 0.85 | — | — | |
| Water SCHEMBL1155688 | 0.85 | TSHR (0.45) | ALDH1A1CA1CA2CA9CYP1A2 | |
| SCHEMBL28281167 | 0.85 | TSHR (0.45) | ALDH1A1CA1CA2CA9CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 399 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250115774-A1 | HIGH PERFORMANCE THERMOSET RESINS FOR 3D PRINTING | NOGA 3D INNOVATIONS LTD (IL) | 2025-04-10 | — | — | US | claimed |
| EP-4466319-A1 | HIGH PERFORMANCE THERMOSET RESINS FOR 3D PRINTING | Noga 3D Innovations Ltd (IL) | 2024-11-27 | — | — | EP | claimed |
| CN-118574903-A | High performance thermosetting resins for 3D printing | 诺佳3D创新有限公司 | 2024-08-30 | — | — | CN | claimed |
| WO-2023139579-A1 | HIGH PERFORMANCE THERMOSET RESINS FOR 3D PRINTING | NOGA 3D INNOVATIONS LTD (IL) | 2023-07-27 | — | — | WO | claimed |
| EP-3344676-B1 | CYANATE ESTER DUAL CURE RESINS FOR ADDITIVE MANUFACTURING | CARBON INC (US) | 2023-04-12 | — | — | EP | claimed |
| CN-108350145-B | Cyanate ester dual cure resin for additive manufacturing | 卡本有限公司 | 2021-06-22 | — | — | CN | claimed |
| US-10618892-B2 | Processes for the preparation of a BACE inhibitor | MERCK SHARP & DOHME CORP. (US) | 2020-04-14 | — | — | US | claimed |
| US-20200039975-A1 | PROCESSES FOR THE PREPARATION OF A BACE INHIBITOR | MERCK SHARP & DOHME CORP. (US) | 2020-02-06 | — | — | US | claimed |
| US-10471655-B2 | Cyanate ester dual resins for additive manufacturing | CARBON, INC. (US) | 2019-11-12 | — | — | US | claimed |
| US-20190010343-A1 | CYANATE ESTER DUAL RESINS FOR ADDITIVE MANUFACTURING | CARBON3D INC (US) | 2019-01-10 | — | — | US | claimed |
| EP-1979397-A4 | SHAPE MEMORY CYANATE ESTER COPOLYMERS | CORNERSTONE RES GROUP INC (US) | 2009-04-08 | — | — | EP | claimed |
| EP-1979397-A2 | SHAPE MEMORY CYANATE ESTER COPOLYMERS | CORNERSTONE RESEARCH GROUP, INC. (US) | 2008-10-15 | — | — | EP | claimed |
| WO-2008051241-A2 | SHAPE MEMORY CYANATE ESTER COPOLYMERS | CORNERSTONE RESEARCH GROUP, INC. (US) | 2008-05-02 | — | — | WO | claimed |
| US-7223861-B2 | Process for preparing substituted 5-amino-pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidines | SCHERING CORPORATION (US) | 2007-05-29 | — | — | US | claimed |
| JP-2007509948-A | — | — | 2007-04-19 | — | — | JP | claimed |
| EP-1678182-B1 | PROCESS FOR PREPARING SUBSTITUTED 5-AMINO-PYRAZOLO- [4,3-E]-1,2,4-TRIAZOLO [1,5-C]PYRIMIDINES | SCHERING CORP (US) | 2007-02-07 | — | — | EP | claimed |
| EP-1678182-A1 | PROCESS FOR PREPARING SUBSTITUTED 5-AMINO-PYRAZOLO- [4,3-E]-1,2,4-TRIAZOLO [1,5-C]PYRIMIDINES | Schering Corporation (US) | 2006-07-12 | — | — | EP | claimed |
| WO-2005044819-A1 | PROCESS FOR PREPARING SUBSTITUTED 5-AMINO-PYRAZOLO-[4,3-E]-1,2,4-TRIAZOLO[1,5-C]PYRIMIDINES | SCHERING CORPORATION (US) | 2005-05-19 | — | — | WO | claimed |
| US-20050090492-A1 | Process for preparing substituted 5-amino-pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine | SCHERING CORPORATION | 2005-04-28 | — | — | US | claimed |
| EP-0326931-A2 | Thermosetting resin composition | CYTEC TECHNOLOGY CORP. (US) | 1989-08-09 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200039975-A1 | PROCESSES FOR THE PREPARATION OF A BACE INHIBITOR | BACE2, BACE1, APP | NAAA 3019/4885ALDH1A1 837/4885CA1 399/4885 |
| US-10618892-B2 | Processes for the preparation of a BACE inhibitor | BACE2, BACE1, APP | NAAA 3019/4885ALDH1A1 837/4885CA1 399/4885 |
| US-20050090492-A1 | Process for preparing substituted 5-amino-pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine | TYMP, DCK, TK1 | NAAA 1702/4885ALDH1A1 997/4885CA1 3913/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.